Champions Oncology outlines fiscal 2027 plan with Corellia fully funded as it reports $59.4M revenue and $1.6M adjusted EBITDA (NASDAQ:CSBR)July 27, 2026
Share Facebook Twitter LinkedIn Pinterest Email Markets were volatile April 13, with stocks flipping from losses to gains and oil prices rising after the US began a blockade of the Strait of Hormuz. Read the original article on Business Insider
